Showing results (251-260 of 282) with videos related to
Sort By:
Pageof 29
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
General nature of the STAT3-activated anti-inflammatory responseKarim C El Kasmi, Jeff Holst, Maryaline Coffre, et al.Cancer Immunology Research|May 19, 2022
Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T CellsAshwin Somasundaram, Anthony R Cillo, Caleb Lampenfeld, et al.Brain, Behavior, and Immunity|September 11, 2022
Neuronally expressed PDL1, not PD1, suppresses acute nociceptionKimberly A Meerschaert, Brian S Edwards, Ariel Y Epouhe, et al.Science Immunology|July 19, 2020
Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 sheddingLawrence P Andrews, Ashwin Somasundaram, Jessica M Moskovitz, et al.Cancer Immunology Research|February 7, 2020
B cell-Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic CancerBhalchandra Mirlekar, Daniel Michaud, Samuel J Lee, et al.Nature Communications|June 8, 2021
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinomaAyana T Ruffin, Anthony R Cillo, Tracy Tabib, et al.Cell|May 30, 2017
Interferon-γ Drives Treg Fragility to Promote Anti-tumor ImmunityAbigail E Overacre-Delgoffe, Maria Chikina, Rebekah E Dadey, et al.Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanomaLilit Karapetyan, Anthony R Cillo, Shuaichao Wang, et al.Cell|August 9, 2024
LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicityShin Foong Ngiow, Sasikanth Manne, Yinghui Jane Huang, et al.The Journal of Experimental Medicine|October 12, 2020
PD-1 restraint of regulatory T cell suppressive activity is critical for immune toleranceCatherine L Tan, Juhi R Kuchroo, Peter T Sage, et al.Pageof 29